Skip to main content

Modality Specific Analgesia Produced by Intrathecal Anti-Substance P Antibody

  • Conference paper
Substance P and Neurokinins

Abstract

Substance P (SP) is a putative primary afferent transmitter of nociceptive information [1]. Intrathecal injection of SP produces an increased sensitivity to heat [2,3] and pressure [4] in tests for nociceptive thresholds. Recently, SP was shown to be released from spinal cord by noxious pressure but not noxious thermal stimulation, while somatostatin (SST) was selectively released by noxious thermal stimulation [5] suggesting a modality specific role for these peptides in relation to pain. Previously, antibodies to SP (anti-SP) and SST (anti-SST) have been used to demonstrate the presence of SP and SST immunoreactive fibers in the dorsal horn of the spinal cord [6]. In this study we have used antibodies to SP and SST to determine whether a modality specific analgesia for these peptides could be demonstrated. The present experiments first tested the tail flick latency to heat and the paw withdrawal response to pressure in rats following intrathecal injections of anti SP, anti-SST or normal serum. In a second experiment, the behavioral effects of anti-SP serum were compared to normal serum in rats which were tested prior to injection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nicoll RA, Schenker C, Leeman SE (1980) Substance P as a transmitter candidate. Ann Rev Neurosci 3: 227–268

    Article  PubMed  CAS  Google Scholar 

  2. Yasphal K, Wright OM, Henry JL (1982) Substance P reduces tail flick latency: implications for chronic pain syndromes. Pain 14: 155–167

    Article  PubMed  CAS  Google Scholar 

  3. Moochhala SM, Sawynok J (1984) Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization. Br J Pharmac 82: 381–388

    CAS  Google Scholar 

  4. Matsumara H, Sakurada T, Hara A, Sakurada S, Kisara K (1985) Characterization of the hyperalgesic effect induced by intrathecal injection of substance P. Neuropharmacology 24: 421–426

    Article  Google Scholar 

  5. Kuriashi Y, Hirota N, Sato Y, Hino Y, Satoh M, Takagi H (1985) Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Research 325: 294–298

    Article  Google Scholar 

  6. Hökfelt T, Elde R, Johansson O, Luft R, Nilsson G, Arimura A (1976) Immunohistochemical evidence for separate opulations of somatostatincontaining and substance P-containing primary afferent neurons in the rat. Neuroscience 1: 131–136

    Article  PubMed  Google Scholar 

  7. Chrubisak J, Meynadier J, Blond S, Scherpereel P, Ackerman E, Weinstock M, Bonath K, Cramer H, Wünsch E (1984) Somatostatin, a potent analgesic. Lancet ii: 1208–1209

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag New York Inc.

About this paper

Cite this paper

Nance, P.W., Sawynok, J., Nance, D.M. (1987). Modality Specific Analgesia Produced by Intrathecal Anti-Substance P Antibody. In: Henry, J.L., Couture, R., Cuello, A.C., Pelletier, G., Quirion, R., Regoli, D. (eds) Substance P and Neurokinins. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4672-5_95

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4672-5_95

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9109-1

  • Online ISBN: 978-1-4612-4672-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics